While previous research within the Whitehall cohort [5] has demonstrated changes in glycemia, insulin sensitivity and insulin secretion became apparent years before the clinical diagnosis and prior to the onset of T2D, it remains unclear whether different trajectories in diabetes-related health parameters exist across T2D-related diabetes subtypes [2]. This evidence concerns the gene INS and type 2 diabetes mellitus.